Pancreatic Cancer Research

ResearcherDalian Medical UniversityNo recent work listed

Zechang Xin

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5035566460. Sources: OpenAlex.

Their work

Papers
7 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2020: 3 papers · 2021: 3 papers · 2022: 1 paper

Papers 7

  1. The long non-coding RNA EGOT promotes pancreatic cancer progression by sequestering miR-214 to derepress PLS3 expression Co-author DOI 10.21203/rs.3.rs-1415870/v1↗
  2. Overexpressed CA12 has prognostic value in pancreatic cancer and promotes tumor cell apoptosis via NF-κB signaling. First author DOI 10.1007/s00432-020-03447-9↗
  3. Discovery and Validation of Circulating EVL mRNA as a Prognostic Biomarker in Pancreatic Cancer. Co-author DOI 10.1155/2021/6656337↗
  4. Expression and prognostic analyses of SCAMPs in pancreatic adenocarcinoma. Co-author DOI 10.18632/aging.202377↗
  5. PLS3 predicts poor prognosis in pancreatic cancer and promotes cancer cell proliferation via PI3K/AKT signaling. Co-author DOI 10.1002/jcp.29685↗
  6. High Expression of COL17A1 Predicts Poor Prognosis and Promotes the Tumor Progression via NF-κB Pathway in Pancreatic Adenocarcinoma. Co-author DOI 10.1155/2020/8868245↗
  7. Distal pancreatectomy with en bloc celiac axis resection does not improve the R0 rate or median survival time of patients with locally advanced pancreatic canc… First author DOI 10.21037/tcr-19-2421↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jie J. Yao · 6 shared papers, 2020–2022 · strength 0.82
  2. Feiyu Mao · 6 shared papers, 2020–2021 · strength 0.79
  3. Yan Du · 5 shared papers, 2020–2021 · strength 0.66
  4. Peng Xu · 5 shared papers, 2020–2021 · strength 0.66
  5. Jianjun Qian · 4 shared papers, 2020–2022 · strength 0.51
  6. Zhennan Li · 4 shared papers, 2020–2022 · strength 0.51
  7. Qingbo Feng · 2 shared papers, 2020–2021 · strength 0.27
  8. Duguang Li · 2 shared papers, 2020 · strength 0.23
  9. Lijie Cai · 1 shared paper, 2022 · strength 0.16
  10. Peng Liu · 1 shared paper, 2022 · strength 0.16
  11. Jie J. Yao · 1 shared paper, 2020 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.